Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer-Associated Thrombosis (CAT)”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07493304
What this trial is testing

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Who this might be right for
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 1,600
Not applicableStudy completedNCT04846556
What this trial is testing

Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO

Who this might be right for
Venous ThromboembolismCancer
Centre Hospitalier Universitaire de Saint Etienne 300
Not applicableLooking for participantsNCT06714734
What this trial is testing

Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT

Who this might be right for
Venous Thromboembolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07303816
What this trial is testing

Statins to Prevent Cancer Associated Blood Clots

Who this might be right for
Venous ThromboembolismCancerCardiovascular Events
Brigham and Women's Hospital 4,000
Not applicableLooking for participantsNCT06386107
What this trial is testing

Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis

Who this might be right for
CancerPulmonary EmbolismThrombosis
Centre Hospitalier Universitaire de Saint Etienne 212
Not applicableUnknownNCT03909399
What this trial is testing

Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients

Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismVena Cava Thrombosis+1 more
Hellenic Society of Medical Oncology 500
Large-scale testing (Phase 3)Ended earlyNCT05171049
What this trial is testing

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 1,150
Large-scale testing (Phase 3)Ended earlyNCT05171075
What this trial is testing

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 417
Large-scale testing (Phase 3)Looking for participantsNCT07410117
What this trial is testing

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

Who this might be right for
Cancer-Associated Thrombosis (CAT)
Regeneron Pharmaceuticals 860
Not applicableEnded earlyNCT02752607
What this trial is testing

Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots

Who this might be right for
Deep Vein Thrombosis
Dr. Vicky Tagalakis 52
Large-scale testing (Phase 3)Study completedNCT03692065
What this trial is testing

API-CAT STUDY for APIxaban Cancer Associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Assistance Publique - Hôpitaux de Paris 1,766